Hydrastine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 6,7-dimethoxy-3-(6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| CAS number | 118-08-1 |
| ATC code | None |
| PubChem | CID 197835 |
| ChemSpider | 171234 |
| UNII | 8890V3217X |
| Chemical data | |
| Formula | C21H21NO6 |
| Mol. mass | 383.395 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Hydrastine is a natural alkaloid which was discovered in 1851 by Alfred P. Durand.[1] Hydrolysis of hydrastine yields hydrastinine, which was patented by Bayer as a haemostatic drug[2] during the 1910s.
It is naturally present in Hydrastis canadensis (thus the name) and other plants of the ranunculaceae family.
[edit] References
| This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
| This biochemistry article is a stub. You can help Wikipedia by expanding it. |